What is it about?
Our study recruited people with diabetes who have developed painful neuropathy that does not respond to currently available medications. We tested a new treatment option that involves implanting a device that works like a pacemaker for pain by delivering mild electrical impulses to the spinal cord. This technology is called high-frequency 10 kilohertz spinal cord stimulation (10 kHz SCS) and was recently approved by the U.S. Food and Drug Administration as a treatment for pain due to diabetic neuropathy. Our results demonstrate effective pain relief sustained over a 12 month follow-up period.
Photo by Imani Bahati on Unsplash
Why is it important?
Pain from diabetic neuropathy is a very common condition and, unfortunately, many people experience inadequate relief with the best treatments currently available. The results from our study establish 10 kHz SCS as a safe and extremely effective approach for people suffering with diabetic neuropathy. Not only did our study participants enjoy substantial, long-lasting pain relief, but many of them also experienced improved sensation in their feet.
Read the Original
This page is a summary of: Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial, Diabetes Care, November 2021, American Diabetes Association, DOI: 10.2337/dc21-1813.
You can read the full text:
The following have contributed to this page